20
Participants
Start Date
April 30, 2010
Primary Completion Date
February 28, 2011
Study Completion Date
February 28, 2011
Ranolazine
Intravenous treatment followed oral treatment for 13 days.
Saline 0.9% and placebo tablet
Intravenous treatment followed by oral treatment for 13 days
University Medicine Goettingen (UMG), Göttingen
Lead Sponsor
University Medicine Göttingen, Cardiac Center
UNKNOWN
Gilead Sciences
INDUSTRY